News & Events
In the news
Clean Mails – December 2024
Clean Biologics' News:
Next-Generation Sequencing, Single Cell Cloning, Exosomes, HIV vaccine...
Here is the last edition of our quaterly Clean Mails newsletter. To find out Clean Cells and Naobios' news or to receive our next editions, click here.
Clean Mails – June 2024
Clean Biologics' News:
CHO cell, Oncolytic Virus, Mass Spectrometry...
Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Leveraging CHO cell potential in R&D and cGMP". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.
Clean Mails
Clean Biologics' News:
Single cell cloning, rAAV, Human Viral Challenge Agents...
Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Clean Cells, your partner for single cell cloning to cGMP cell banks". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.
The quarterly scientific journal – October 2023
Clean Mails
Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Increasing biologics manufacturing capacities". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.
The quarterly scientific journal – June 2023
Clean Mails
Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "Assessing the scale-X(TM) bioreactor's biomanufacturing capacities on Vero cells". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.
The quarterly scientific journal – May 2023
Clean Mails
Here is the last edition of our quaterly Clean Mails newsletter, having as main subject: "A new facility to extend biopharma services". To read about this and find out Clean Cells, Naobios and Biodextris' news or to receive our next editions, click here.
Press Release
Clean Cells launches activities at new biopharmaceutical quality control facility - largest in Europe
With 5,300m2 of new premises, €22M building offers four times more laboratory space than previous facility
Biodextris’ Press Release
Biodextris invests in a new biologics Contract Development and Manufacturing Centre (CDMO)
Biodextris invests in a new biologics Contract Development and Manufacturing Centre (CDMO) - With the support of the governments of Quebec and Canada and Investissement Québec